Alumis said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares to a record…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/alumis-shares-surge-record-high-skin-disease-drug-aces-late-2026a10000ca?src=rss
Author :
Publish date : 2026-01-06 12:07:00
Copyright for syndicated content belongs to the linked Source.